California Public Employees Retirement System
RLMD icon

California Public Employees Retirement System’s Relmada Therapeutics RLMD Stock Holding History

California Public Employees Retirement System’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29,400
Closed -$1.03M – 2643
2021
Q1 		$1.03M Sell
29,400
-2,654
-8% -$92.8K ﹤0.01% 2479
2020
Q4 		$1.03M Sell
32,054
-600
-2% -$20.6K ﹤0.01% 2448
2020
Q3 		$1.23M Buy
32,654
+750
+2% +$29K ﹤0.01% 2130
2020
Q2 		$1.43M Buy
+31,904
New +$1.35M ﹤0.01% 1990

Other funds holding RLMD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System's RLMD Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Relmada Therapeutics (RLMD) in Q2 2021, closing a stake of 29,400 shares — an estimated $1.03M sold.

California Public Employees Retirement System first reported a position in RLMD in Q2 2020 and held it in 4 quarters. The position peaked at $1.43M in Q2 2020. 85 funds tracked by Wall St. Rank hold RLMD as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Relmada Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 29,400 Relmada Therapeutics shares in Q2 2021, an estimated $1.03M.
  • California Public Employees Retirement System first reported a position in Relmada Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Relmada Therapeutics position peaked at $1.43M in Q2 2020.
  • 85 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.